Physician profile
Logan Gilmore
NPI 1225513401
$13,173.45
in general payments reported to CMS, 2019-2025
27 companies · $1,724 in 2025
The $1,724 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,592 · 2022: $2,409 · 2023: $3,304 · 2024: $4,145 · 2025: $1,724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,215 · Travel and Lodging: $1,532 · Consulting Fee: $1,425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,215.21 |
| Travel and Lodging | $1,532.48 |
| Consulting Fee | $1,425.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $3,843.81 | 2021-2025 | Carto 3, Decanav, Octaray Mapping Catheter |
| Medical Device Business Services, INC. | $2,312.55 | 2023-2024 | Carto 3 |
| Boston Scientific Corporation | $2,134.65 | 2021-2025 | Farapulse, Watchman Flx, Rhythmia Mapping System |
| Abbott Laboratories | $1,295.73 | 2021-2025 | Ensite, Quartet, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $785.26 | 2022-2024 | Selectsecure, Linq II, Mosaic |
| Impulse Dynamics (USA) INC. | $380.01 | 2022 | |
| Janssen Pharmaceuticals, INC | $377.26 | 2021-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $372.93 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $243.33 | 2021-2025 | Lifevest |
| Pfizer INC. | $215.30 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $159.39 | 2021-2024 | Camzyos |
| Abiomed | $136.41 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $126.30 | 2021 | |
| Novartis Pharmaceuticals Corporation | $107.72 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $101.33 | 2022-2023 | Verquvo |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $100.85 | 2025 | Flowtriever, Artix Mt |
| Irhythm Technologies, INC. | $95.89 | 2021-2023 | Zio Xt Patch |
| Amgen INC. | $89.61 | 2021-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.83 | 2023-2025 | Jardiance |
| Esperion Therapeutics, INC. | $60.96 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $53.20 | 2021-2022 | |
| Philips North America LLC | $33.66 | 2024 | (9124) Lm Undivided |
| Inari Medical, INC. | $20.75 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bayer Healthcare Pharmaceuticals INC. | $19.94 | 2025 | |
| Akcea Therapeutics, INC. | $19.16 | 2021 | |
| Vifor Pharma, INC. | $13.01 | 2021 | |
| Acutus Medical, INC. | $12.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Gilmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.